{"transactions":[{"id":696388,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26427,"kind":"person","name":"Jover Placid","position":1,"cik":"0002026165","reported_name":"Jover Placid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2026-08-05T20:04:34.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":false,"shares":12827,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on August 1, 2024, with 12,827 vested on each of August 1, 2025 and August 1, 2026, 12,827 vesting on August 1, 2027, and 12,830 vesting on August 1, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on August 1, 2024, with 12,827 vested on each of August 1, 2025 and August 1, 2026, 12,827 vesting on August 1, 2027, and 12,830 vesting on August 1, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":25657,"derivative":{"underlying":"Ordinary Shares","underlying_shares":12827},"source":{"system":"sec-edgar","filing":"0001193125-26-335026","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526335026/ownership.xml","form_type":"4"}},{"id":696387,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26427,"kind":"person","name":"Jover Placid","position":1,"cik":"0002026165","reported_name":"Jover Placid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2026-08-05T20:04:34.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":12827,"price":34.8757,"value":447350.6039,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents with respect to the vesting of restricted share units, the reporting person sold all such shares vested, including shares to cover tax witholding obligations in connection with the vesting."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.66 to $35.07, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":6774,"source":{"system":"sec-edgar","filing":"0001193125-26-335026","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526335026/ownership.xml","form_type":"4"}},{"id":696386,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26427,"kind":"person","name":"Jover Placid","position":1,"cik":"0002026165","reported_name":"Jover Placid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2026-08-05T20:04:34.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":true,"shares":12827,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":19601,"source":{"system":"sec-edgar","filing":"0001193125-26-335026","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526335026/ownership.xml","form_type":"4"}},{"id":854913,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26427,"kind":"person","name":"Jover Placid","position":1,"cik":"0002026165","reported_name":"Jover Placid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2026-03-09T20:10:30.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":false,"shares":14150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 5, 2025, with 14,150 vesting on each of March 5, 2026, March 5, 2027 and March 5, 2028, and 14,153 vesting on March 5, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 5, 2025, with 14,150 vesting on each of March 5, 2026, March 5, 2027 and March 5, 2028, and 14,153 vesting on March 5, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":42453,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14150},"source":{"system":"sec-edgar","filing":"0001193125-26-098506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098506/ownership.xml","form_type":"4"}},{"id":854912,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26427,"kind":"person","name":"Jover Placid","position":1,"cik":"0002026165","reported_name":"Jover Placid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:10:30.000Z","date":"2026-03-05","kind":"sale","planned":true,"acquired":false,"shares":14150,"price":31.6684,"value":448107.86,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents with respect to the vesting of restricted share units, the reporting person sold all such shares vested, including shares to cover tax witholding obligations in connection with the vesting."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.26 to $32.34, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":6774,"source":{"system":"sec-edgar","filing":"0001193125-26-098506","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098506/ownership.xml","form_type":"4"}},{"id":854911,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26427,"kind":"person","name":"Jover Placid","position":1,"cik":"0002026165","reported_name":"Jover Placid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2026-03-09T20:10:30.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":true,"shares":14150,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":20924,"source":{"system":"sec-edgar","filing":"0001193125-26-098506","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526098506/ownership.xml","form_type":"4"}},{"id":857157,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26427,"kind":"person","name":"Jover Placid","position":1,"cik":"0002026165","reported_name":"Jover Placid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2026-03-06T21:16:10.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":37982,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on March 4, 2026, with 9,495 vesting on each of March 4, 2027, March 4, 2028 and March 4, 2029, and 9,497 vesting on March 4, 2030."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on March 4, 2026, with 9,495 vesting on each of March 4, 2027, March 4, 2028 and March 4, 2029, and 9,497 vesting on March 4, 2030."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":37982,"derivative":{"underlying":"Ordinary Shares","underlying_shares":37982},"source":{"system":"sec-edgar","filing":"0001193125-26-096569","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000119312526096569/ownership.xml","form_type":"4"}},{"id":1075567,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26427,"kind":"person","name":"Jover Placid","position":1,"cik":"0002026165","reported_name":"Jover Placid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2025-08-05T20:04:57.000Z","date":"2025-08-01","kind":"exercise","planned":false,"acquired":false,"shares":12827,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on August 1, 2024, with 12,827 vested on August 1, 2025, 12,827 vesting on each of August 1, 2026 and August 1, 2027, and 12,830 vesting on August 1, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on August 1, 2024, with 12,827 vested on August 1, 2025, 12,827 vesting on each of August 1, 2026 and August 1, 2027, and 12,830 vesting on August 1, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":38484,"derivative":{"underlying":"Ordinary Shares","underlying_shares":12827},"source":{"system":"sec-edgar","filing":"0000950170-25-102992","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025102992/ownership.xml","form_type":"4"}},{"id":1075566,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26427,"kind":"person","name":"Jover Placid","position":1,"cik":"0002026165","reported_name":"Jover Placid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2025-08-05T20:04:57.000Z","date":"2025-08-01","kind":"sale","planned":false,"acquired":false,"shares":6053,"price":15.1575,"value":91748.3475,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.13 to $15.31, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":6774,"source":{"system":"sec-edgar","filing":"0000950170-25-102992","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025102992/ownership.xml","form_type":"4"}},{"id":1075565,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26427,"kind":"person","name":"Jover Placid","position":1,"cik":"0002026165","reported_name":"Jover Placid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Ordinary Shares","published_at":"2025-08-05T20:04:57.000Z","date":"2025-08-01","kind":"exercise","planned":false,"acquired":true,"shares":12827,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":12827,"source":{"system":"sec-edgar","filing":"0000950170-25-102992","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025102992/ownership.xml","form_type":"4"}},{"id":1218508,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26427,"kind":"person","name":"Jover Placid","position":1,"cik":"0002026165","reported_name":"Jover Placid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2025-03-07T21:07:32.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":56603,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on March 5, 2025, with 14,150 vesting on each of March 5, 2026, March 5, 2027 and March 5, 2028, and 14,153 vesting on March 5, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on March 5, 2025, with 14,150 vesting on each of March 5, 2026, March 5, 2027 and March 5, 2028, and 14,153 vesting on March 5, 2029."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":56603,"derivative":{"underlying":"Ordinary Shares","underlying_shares":56603},"source":{"system":"sec-edgar","filing":"0000950170-25-035498","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017025035498/ownership.xml","form_type":"4"}},{"id":1441643,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":26427,"kind":"person","name":"Jover Placid","position":1,"cik":"0002026165","reported_name":"Jover Placid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See \"Remarks\""}}],"security":"Restricted Share Units","published_at":"2024-08-05T11:32:25.000Z","date":"2024-08-01","kind":"grant","planned":false,"acquired":true,"shares":51311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on August 1, 2024, with 12,827 vesting on each of August 1, 2025, August 1, 2026 and August 1, 2027 and 12,830 vesting on August 1, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on August 1, 2024, with 12,827 vesting on each of August 1, 2025, August 1, 2026 and August 1, 2027 and 12,830 vesting on August 1, 2028."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":51311,"derivative":{"underlying":"Ordinary Shares","underlying_shares":51311},"source":{"system":"sec-edgar","filing":"0000950170-24-090326","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818686/000095017024090326/ownership.xml","form_type":"4"}}]}